You are here

Article Text

Article menu
Download PDFPDF
Commentary
Treatment of patients with dual hepatitis B and C: a step in the right direction

https://doi.org/10.1136/gutjnl-2013-305115

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors AA and MC: conception and design, drafting the article and final approval of the version to be published.

    • Competing interests AA: grant and research support (Roche, Gilead Sciences); speaking and teaching (Roche, Janssen, Merck). MC: grant and research support (Merck, Roche, BMS, Gilead Science); advisory committees (Merck, Roche, Novartis, Bayer, BMS, Gilead Science, Tibotec, Vertex, Achillion); speaking and teaching (Tibotec, Roche, Novartis, Bayer, BMS, Gilead Science, Vertex).

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles